P1.13-23 TP53 Mutations as Mechanisms of Primary and Acquired Resistance to Tyrosine Kinase Inhibitors in Patients With EGFR-Mutated NSCLC

Saved in:
Bibliographic Details
Published inJournal of thoracic oncology Vol. 13; no. 10; p. S591
Main Authors Canale, M., Ludovini, V., Crinò, L., Dazzi, C., Chiadini, E., Capelli, L., Papi, M., Mariotti, M., De Luigi, N., Minuti, G., Calistri, D., Baglivo, S., Chiari, R., Bonafè, M., Delmonte, A., Ulivi, P.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.10.2018
Online AccessGet full text

Cover

More Information
ISSN:1556-0864
1556-1380
DOI:10.1016/j.jtho.2018.08.880